All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.

Thomas E. Hutson, D.O., Pharm.D., Ph.D., chief of the Hematology Oncology Division in the Department of Internal Medicine at ...

The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.

Integrative cancer care merges conventional treatments like chemotherapy and surgery with research-based traditional medicine ...

Using 3D bioprinting, researchers have developed a more effective method for testing potential HSV treatments.

Vascarta's transdermal curcumin gel formulation ("VAS-101") experienced reduced pain and inflammation along with improved red blood cell stability and functionality. Based in part on these favorable ...

The global Immunohistochemistry Market is valued at an estimated USD 3.4 billion in 2024 and is projected to reach USD 5.2 ...

Health insurers no longer completely cover two breast cancer drugs for women with metastasised hormone receptive breast cancer because of high costs. Three types of drugs – palbociclib, ribociclib and ...

Brewers principal owner Mark Attanasio dealt with the loss of Bob Uecker and then his mother in the offseason. Tuesday, his ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Dutch health insurers have stopped fully covering two of three medicines for metastatic hormonal breast cancer. Since January ...

A top FDA official has quit over layoffs in the food division, warning the agency’s ability to protect public health will be ...